Amlexanox

FDA Approved: * September 29, 2004
Pharm Company: * ULURU
Category: Ulcer

Amlexanox (trade name Aphthasol) is an anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions. This drug has been discontinued in the U.S.[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Mechanism of action 5 Chemistry 6 Pharmacokinetics 7 History 8 Society and culture 8.1 Economics 9 Research 10 Synthesis 11 References Medical uses Amlexanox is the activ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.